Quantcast

Inhalant Speeds Covid Recovery, Saves Lives

Trial demonstrates efficacy of inhaled budesonide to treat COVID-19 in the community

The Royal Pharmaceutical Society – Findings from the PRINCIPLE trial suggest that inhaled budesonide can improve recovery time and could reduce hospital admissions or death from COVID-19 if administered early.

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance.

To learn more about coronavirus, please visit: https://www.rpharms.com/coronavirus

Inhaled budesonide should be considered for patients with COVID-19 who are at higher risk of complications in the community, according to results from a UK-wide clinical study.

The ‘Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses’ (PRINCIPLE) is the first randomised trial to demonstrate effectiveness of inhaled budesonide to treat COVID-19 in the community.

...article continued below
- Advertisement -

It builds on earlier evidence from the phase II ‘Steroids in COVID-19’ (STOIC) trial, which found that early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and reduced time to recovery after early COVID-19.

Findings from the PRINCIPLE trial, published in the Lancet on 10 August 2021, suggested that inhaled budesonide improves recovery time and could potentially reduce hospital admissions or death.

Eligible participants included those who were aged 65 years or older, or aged 50 years or older with comorbidities, who had been unwell for up to 14 days with suspected COVID-19, but had not been admitted to hospital.

Overall, 4,700 participants were randomly assigned to either usual care (n=1,988), usual care plus 800μg of inhaled budesonide twice daily for 14 days (n=1,073), or usual care plus other interventions (n=1,639), and were then followed up for 28 days. The primary endpoints were time to first self-reported recovery, and hospital admission or death related to COVID-19, within 28 days.

Researchers found that, compared with the usual care group, participants using inhaled budesonide recovered an estimated 2.94 days sooner, had a greater sense of wellbeing while recovering and, once recovered, more often remained well.

...article continued below
- Advertisement -

For the hospital admission or death outcome, the estimated rate was 6.8% in the budesonide group, compared with 8.8% in the usual care group; although this failed to meet the superiority threshold.

The authors said that this failure resulted from decrease in hospital admissions, which may have been a result of the UK vaccination programme and lockdown measures.

They added: “Overall, the consistency of these findings across both primary and secondary endpoints provides the strongest evidence thus far of an effective, safe, cheap and readily available treatment for COVID-19 in the community.”

According to the authors of the study, early on in the COVID-19 pandemic, the low prevalence of asthma and chronic obstructive pulmonary disease among people admitted to hospital with COVID-19 led to speculation that the inhaled corticosteroids used to treat these conditions might be protective.

However, until now, there have been no results reported from large effectiveness trials of inhaled budesonide for COVID-19.

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance. SOURCE. 

 

- Advertisement -

TRENDING

Unvaxxed Sailors Face “Serious Consequences”

The Navy said Thursday that those who don't get an approved exemption by the deadline "will receive no lower than a general discharge under honorable conditions" and that "this type of discharge could result in the loss of some veterans’ benefits."

COVID Cases Still Rising In 5 States

THE HILL – Cases of COVID-19 are declining across the country, with 90 percent of states seeing numbers either sustained or going down over...

Bill Clinton Hospitalized With Sepsis

Former President Bill Clinton was admitted to a Southern California hospital with an infection but is "on the mend," his spokesman said.

New Sex Charges Against ‘Predator’ Bill Cosby

"The Pennsylvania Supreme Court let a predator back on the streets." – Cosby accuser Lili Bernard

Animal Rights Law Lays An Egg

Egg-laying hens are required to have 1 and 1/2 square feet of floor space under a law that was to become effective this month. But it's become clear that few egg producers can meet the Massachusetts standard.

Which COVID Vaccine Boosters Work Best?

A study by the National Institutes of Health this week suggests people who got the J&J vaccine as their initial vaccination against the coronavirus may get their best protection from choosing an mRNA vaccine as the booster.

Unvaxxed United Employees Win Reprieve

A federal judge has extended a ban on United Airlines putting employees on unpaid leave for seeking a medical or religious exemption from the airline's requirement to get vaccinated against COVID-19.

Walgreen’s Accidentally Injects Tots With Covid Vaccine

Two children were mistakenly given the Covid-19 vaccine instead of a flu shot a week ago at their local pharmacy -- and are now dealing with some adverse symptoms.

Biden Pushes Largest Permanent Food Stamp Increase Ever

FOUNDATION FOR ECONOMIC EDUCATION – The Biden administration has just introduced the largest increase in the history of the food stamp program (now SNAP, for...

Biden/Pelosi Covid Recovery Spending Plan Fails

House Speaker Nancy Pelosi could have been speaking for the majority of Democrats in Washington when she said on Tuesday that she was “very disappointed” that President Biden’s domestic agenda will have to be pared down because of opposition from Democratic Sens. Joe Manchin of West Virginia and Kyrsten Sinema of Arizona.
- Advertisement -